Summary
- Current Price
- As of today, AQST price is $4.13, unchanged in the most recent trading session on
- Current Price All-Time High
- AQST price is currently -80.04% below its historical high of $20.70 set on
- Market Cap
- AQST current market cap is $504M, up +66.89% over the past 365 days
- PE Ratio
- AQST PE ratio is unknown
- Revenue
- AQST current annual revenue is $44.55M, down -22.61% year-over-year
- Next Earnings
- The next earnings release for AQST is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aquestive Therapeutics, Inc. |
| Ticker | NASDAQ: AQST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aquestive.com |
| Employees | 142 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.13 | |
| Price, 1D Change | 0.00% | |
| $504M | ||
| - | ||
| - | ||
| 1.18 | ||
| $45M | ||
| Revenue, 1Y Change | -22.61% | |
| -$0.78 | ||
| EPS, 1Y Change | -53.98% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.78 | ||
| EPS Estimate | N/A | -$0.46 |
| EPS Est. Change | N/A | +41.30% |
| $44.55M | ||
| Revenue Estimate | N/A | $48.07M |
| Revenue Est. Change | N/A | +7.92% |
| Current Price | $4.13 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +117.92% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.42 | -$0.51 | -20.45% | |
| -$0.59 | -$0.78 | -32.81% | |
| -$0.46 | N/A | +41.30% | |
| -$0.58 | N/A | +25.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $57.50M | $57.56M | +0.11% | |
| $44.81M | $44.55M | -0.59% | |
| $48.07M | N/A | +7.92% | |
| $71.85M | N/A | +61.30% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.13 | |
| $4.80 | ||
| SMA 200 vs Price | +16.33% | |
| $3.93 | ||
| SMA 50 vs Price | -4.78% | |
| 1.18 | ||
| $0.20 | ||
| 51.63 | ||
| 52.40% | ||
| 89.90% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $44.55M | ||
| -$0.78 | ||
| $25.99M | ||
| 58.35% | ||
| -$71.05M | ||
| -159.50% | ||
| -$83.78M | ||
| -188.09% | ||
| -$70.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -3.90 | ||
| 3.14 | ||
| 3.01 | ||
| - | ||
| 2 | ||
| -2.73 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 11.31 | ||
| -14.97 | ||
| -7.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$33.66M | ||
| $121.17M | ||
| $162.17M | ||
| $149.27M | ||
| $195.83M | ||
| $47.61M | ||
| $131.45M | ||
| $11.63M | ||
| $29.86M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $128.33M | ||
| $97.04M | ||
| $18.56M | ||
| $0.00 | ||
| $548.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$52.43M | ||
| -$562.00K | ||
| $102.62M | ||
| $562.00K | ||
| -$52.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| JMP Securities | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Lake Street | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with AQST
FAQ
What is the ticker symbol for Aquestive Therapeutics, Inc.?
The ticker symbol for Aquestive Therapeutics, Inc. is NASDAQ:AQST
Does Aquestive Therapeutics, Inc. pay dividends?
No, Aquestive Therapeutics, Inc. does not pay dividends
What sector is Aquestive Therapeutics, Inc. in?
Aquestive Therapeutics, Inc. is in the Healthcare sector
What industry is Aquestive Therapeutics, Inc. in?
Aquestive Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Aquestive Therapeutics, Inc. based in?
Aquestive Therapeutics, Inc. is headquartered in United States
When did Aquestive Therapeutics, Inc. go public?
Aquestive Therapeutics, Inc. initial public offering (IPO) was on July 25, 2018
Is Aquestive Therapeutics, Inc. in the S&P 500?
No, Aquestive Therapeutics, Inc. is not included in the S&P 500 index
Is Aquestive Therapeutics, Inc. in the NASDAQ 100?
No, Aquestive Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aquestive Therapeutics, Inc. in the Dow Jones?
No, Aquestive Therapeutics, Inc. is not included in the Dow Jones index
When was Aquestive Therapeutics, Inc. last earnings report?
Aquestive Therapeutics, Inc.'s most recent earnings report was on March 4, 2026
When does Aquestive Therapeutics, Inc. report earnings?
The next expected earnings date for Aquestive Therapeutics, Inc. is May 12, 2026
Data Sources & References
- AQST Official Website www.aquestive.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1398733/000139873326000018/0001398733-26-000018-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1398733/000139873326000018/0001398733-26-000018-index.htm
- AQST Profile on Yahoo Finance finance.yahoo.com/quote/AQST
- AQST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aqst